VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings
VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 수시공시의무관련사항(공정공시)(코로나19 검체수송배지 등 공급계약 건) | 2022-02-25 | Korean | |
| 전환가액의조정(제19차) | 2022-02-17 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2022-01-21 | Korean | |
| 전환가액의조정(제13회차) | 2022-01-17 | Korean | |
| 전환사채(해외전환사채포함)발행후만기전사채취득(제13회차) | 2022-01-17 | Korean | |
| 전환가액의조정(제19회차) | 2022-01-17 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
7 filings
| |||||
| 8806394 | 수시공시의무관련사항(공정공시)(코로나19 검체수송배지 등 공급계약 건) | 2022-02-25 | Korean | ||
| 8813706 | 전환가액의조정(제19차) | 2022-02-17 | Korean | ||
| 8831959 | 주식등의대량보유상황보고서(약식) | 2022-01-21 | Korean | ||
| 8833990 | 전환가액의조정(제13회차) | 2022-01-17 | Korean | ||
| 8833989 | 전환사채(해외전환사채포함)발행후만기전사채취득(제13회차) | 2022-01-17 | Korean | ||
| 8833983 | 전환가액의조정(제19회차) | 2022-01-17 | Korean | ||
| 8834300 | 전환사채(해외전환사채포함)발행후만기전사채취득(제16회차, 제17회차) | 2022-01-14 | Korean | ||
|
2021
8 filings
| |||||
| 8847079 | 주식등의대량보유상황보고서(약식) | 2021-12-22 | Korean | ||
| 8850420 | 증권발행결과(자율공시)(제19회차 CB) | 2021-12-17 | Korean | ||
| 8854600 | 주주명부폐쇄기간또는기준일설정 | 2021-12-14 | Korean | ||
| 8857608 | 신주인수권부사채(해외신주인수권부사채포함)발행후만기전사채취득(제5회차) | 2021-12-09 | Korean | ||
| 8861674 | [기재정정]주요사항보고서(전환사채권발행결정) | 2021-11-30 | Korean | ||
| 8862634 | 전환가액의조정(제16회, 제18회) | 2021-11-29 | Korean | ||
| 8867667 | 전환가액의조정(제13회차) | 2021-11-18 | Korean | ||
| 8867431 | 기타주요경영사항(13회차 전환가액 조정 취소) | 2021-11-18 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
VIVOZON PHARMACEUTICAL CO., LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15941/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15941 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15941 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15941 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15941}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for VIVOZON PHARMACEUTICAL CO., LTD. (id: 15941)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.